10070: MET-02 NON-SMALL-CELL LUNG CANCER WITH SYNCHRONOUS BRAIN METASTASIS IN THE ERA OF MOLECULAR TARGETED DRUGS: TREATMENT OUTCOME AND RISK FACTORS

por Uzuka, Takeo, Higuchi, Fumi, Kim, Phyo, Ueki, Keisuke
Publicado 2019

Intravascular Lymphoma with an Acute Course of Cerebellar Hemorrhage: A Case Report

por UZUKA, Takeo, HIGUCHI, Fumi, MATSUDA, Hadzuki, OTANI, Ryohei, KIM, Phyo, UEKI, Keisuke
Publicado 2018

MPC-07 MECHANISMS OF BETTER PROGNOSIS IN IDH-MUTATED ASTROCYTOMA WITH 19Q-LOSS

por Otani, Ryohei, Uzuka, Takeo, Higuchi, Fumi, Matsuda, Hadzki, Kim, Phyo, Ueki, Keisuke
Publicado 2019

Surgical Site Infection after Malignant Brain Tumor Resection: A Multicenter Study for Induction of a Basic Care Bundle

por UZUKA, Takeo, TAKAHASHI, Hideaki, NAKASU, Yoko, OKUDA, Takeshi, MITSUYA, Koichi, HAYASHI, Nakamasa, HIROSE, Takayuki, KURAI, Hanako
Publicado 2017

MPC-11 Comprehensive gene expression analysis of IDH-mutated astrocytomas with 19q-loss

por Otani, Ryohei, Mukasa, Akitake, Uzuka, Takeo, Higuchi, Fumi, Matsuda, Hadzki, Tanaka, Shota, Kim, Phyo, Ueki, Keisuke
Publicado 2020

IDH‐mutated astrocytomas with 19q‐loss constitute a subgroup that confers better prognosis

por Otani, Ryohei, Uzuka, Takeo, Higuchi, Fumi, Matsuda, Hadzki, Nomura, Masashi, Tanaka, Shota, Mukasa, Akitake, Ichimura, Koichi, Kim, Phyo, Ueki, Keisuke
Publicado 2018

Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study

por Nagane, Motoo, Ichimura, Koichi, Onuki, Ritsuko, Narushima, Daichi, Honda-Kitahara, Mai, Satomi, Kaishi, Tomiyama, Arata, Arai, Yasuhito, Shibata, Tatsuhiro, Narita, Yoshitaka, Uzuka, Takeo, Nakamura, Hideo, Nakada, Mitsutoshi, Arakawa, Yoshiki, Ohnishi, Takanori, Mukasa, Akitake, Tanaka, Shota, Wakabayashi, Toshihiko, Aoki, Tomokazu, Aoki, Shigeki, Shibui, Soichiro, Matsutani, Masao, Ishizawa, Keisuke, Yokoo, Hideaki, Suzuki, Hiroyoshi, Morita, Satoshi, Kato, Mamoru, Nishikawa, Ryo
Publicado 2022

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

por Arita, Hideyuki, Yamasaki, Kai, Matsushita, Yuko, Nakamura, Taishi, Shimokawa, Asanao, Takami, Hirokazu, Tanaka, Shota, Mukasa, Akitake, Shirahata, Mitsuaki, Shimizu, Saki, Suzuki, Kaori, Saito, Kuniaki, Kobayashi, Keiichi, Higuchi, Fumi, Uzuka, Takeo, Otani, Ryohei, Tamura, Kaoru, Sumita, Kazutaka, Ohno, Makoto, Miyakita, Yasuji, Kagawa, Naoki, Hashimoto, Naoya, Hatae, Ryusuke, Yoshimoto, Koji, Shinojima, Naoki, Nakamura, Hideo, Kanemura, Yonehiro, Okita, Yoshiko, Kinoshita, Manabu, Ishibashi, Kenichi, Shofuda, Tomoko, Kodama, Yoshinori, Mori, Kanji, Tomogane, Yusuke, Fukai, Junya, Fujita, Koji, Terakawa, Yuzo, Tsuyuguchi, Naohiro, Moriuchi, Shusuke, Nonaka, Masahiro, Suzuki, Hiroyoshi, Shibuya, Makoto, Maehara, Taketoshi, Saito, Nobuhito, Nagane, Motoo, Kawahara, Nobutaka, Ueki, Keisuke, Yoshimine, Toshiki, Miyaoka, Etsuo, Nishikawa, Ryo, Komori, Takashi, Narita, Yoshitaka, Ichimura, Koichi
Publicado 2016